<DOC>
	<DOCNO>NCT01896531</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled study evaluate efficacy GDC-0068 combination oxaliplatin , 5-fluorouracil , leucovorin ( modify FOLFOX6 [ mFOLFOX6 ] ) chemotherapy participant advance metastatic gastric gastroesophageal junction ( GEJ ) cancer . Participants randomize receive either GDC-0068 placebo orally daily Days 1 7 14-day cycle combination mFOLFOX6 Day 1 cycle . Anticipated time study treatment disease progression unacceptable toxicity occur ( approximately 2 year ) .</brief_summary>
	<brief_title>A Study GDC-0068 Combination With Fluoropyrimidine Plus Oxaliplatin Participants With Advanced Metastatic Gastric Gastroesophageal Junction Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Histologically document , inoperable locally advanced metastatic recurrent gastric/GEJ adenocarcinoma , amenable curative therapy Measurable disease , accord RECIST v1.1 Life expectancy great equal ( &gt; /= ) 12 week Adequate hematologic organ function Previous chemotherapy inoperable locally advanced metastatic gastric/GEJ adenocarcinoma . Participants may receive prior neoadjuvant adjuvant chemotherapy and/or radiation treatment locally advance gastric/GEJ adenocarcinoma , provide treatment complete &gt; /= 6 month prior randomization . Known human epidermal growth factor receptor 2 ( HER2 ) positive gastric/GEJ adenocarcinoma Radiation treatment within 28 day randomization . Participants receive palliative radiation treatment peripheral site ( eg , bone metastasis ) within 28 day randomization may enrol study recover acute , reversible effect notification Medical Monitor . Previous therapy gastric/GEJ adenocarcinoma Akt , phosphatidylinositol 3kinase ( PI3K ) , and/or mammalian target rapamycin ( mTOR ) inhibitor Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior randomization anticipation need major surgical procedure course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>